Karen S. Kelly‐Spratt

3.2k total citations · 1 hit paper
24 papers, 2.0k citations indexed

About

Karen S. Kelly‐Spratt is a scholar working on Molecular Biology, Oncology and Spectroscopy. According to data from OpenAlex, Karen S. Kelly‐Spratt has authored 24 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Spectroscopy. Recurrent topics in Karen S. Kelly‐Spratt's work include Advanced Proteomics Techniques and Applications (7 papers), Cancer-related Molecular Pathways (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Karen S. Kelly‐Spratt is often cited by papers focused on Advanced Proteomics Techniques and Applications (7 papers), Cancer-related Molecular Pathways (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Karen S. Kelly‐Spratt collaborates with scholars based in United States, Switzerland and Russia. Karen S. Kelly‐Spratt's co-authors include Christopher J. Kemp, Michael C. Jensen, Virginia J. Hoglund, Catherine Lindgren, Olivia Finney, Christopher Brown, Julie R. Park, Stephanie Mgebroff, Assaf P. Oron and Rebecca Gardner and has published in prestigious journals such as Genes & Development, Blood and PLoS ONE.

In The Last Decade

Karen S. Kelly‐Spratt

24 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults

2017 787 citations Rebecca Gardner, Olivia Finney et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen S. Kelly‐Spratt United States	17	1.3k	1.0k	356	318	297	24	2.0k
Robert Eil United States	14	1.1k 0.8×	739 0.7×	30 0.1×	197 0.6×	257 0.9×	30	2.1k
Alberto Peláez‐García Spain	21	326 0.3×	821 0.8×	86 0.2×	43 0.1×	135 0.5×	44	1.3k
Janneke E. Jaspers Netherlands	15	1.5k 1.2×	1.4k 1.3×	24 0.1×	388 1.2×	64 0.2×	17	2.0k
Jillian Smith United States	8	1.8k 1.4×	541 0.5×	18 0.1×	390 1.2×	574 1.9×	16	2.2k
Christopher J. Tape United Kingdom	20	637 0.5×	548 0.5×	70 0.2×	57 0.2×	126 0.4×	36	1.3k
Jeffrey A. Magee United States	17	729 0.6×	1.7k 1.7×	35 0.1×	202 0.6×	102 0.3×	39	2.7k
Kam Sprott United States	12	376 0.3×	756 0.7×	65 0.2×	57 0.2×	127 0.4×	31	1.2k
Robert W. Hsieh United States	8	656 0.5×	625 0.6×	27 0.1×	82 0.3×	55 0.2×	8	1.4k
Mingang Hao China	22	804 0.6×	877 0.8×	71 0.2×	52 0.2×	105 0.4×	32	1.8k
David Clever United States	11	714 0.6×	518 0.5×	24 0.1×	121 0.4×	148 0.5×	20	1.4k

Countries citing papers authored by Karen S. Kelly‐Spratt

Since Specialization

Citations

This map shows the geographic impact of Karen S. Kelly‐Spratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen S. Kelly‐Spratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen S. Kelly‐Spratt more than expected).

Fields of papers citing papers by Karen S. Kelly‐Spratt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen S. Kelly‐Spratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen S. Kelly‐Spratt. The network helps show where Karen S. Kelly‐Spratt may publish in the future.

Co-authorship network of co-authors of Karen S. Kelly‐Spratt

This figure shows the co-authorship network connecting the top 25 collaborators of Karen S. Kelly‐Spratt. A scholar is included among the top collaborators of Karen S. Kelly‐Spratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen S. Kelly‐Spratt. Karen S. Kelly‐Spratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Künkele, Annette, Adam Johnson, Lisa S. Rolczynski, et al.. (2015). Functional Tuning of CARs Reveals Signaling Threshold above Which CD8+ CTL Antitumor Potency Is Attenuated due to Cell Fas–FasL-Dependent AICD. Cancer Immunology Research. 3(4). 368–379. 130 indexed citations

Ruddell, Alanna, et al.. (2014). Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads. BMC Cancer. 14(1). 354–354. 16 indexed citations

Gardner, Rebecca, Julie R. Park, Karen S. Kelly‐Spratt, et al.. (2014). T Cell Products of Defined CD4:CD8 Composition and Prescribed Levels of CD19CAR/Egfrt Transgene Expression Mediate Regression of Acute Lymphoblastic Leukemia in the Setting of Post-Allohsct Relapse. Blood. 124(21). 3711–3711. 7 indexed citations

Busch, Stephanie, Russell Moser, Kay E. Gurley, et al.. (2013). ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma. Oncogene. 33(20). 2665–2673. 13 indexed citations

Pitteri, Sharon J., Karen S. Kelly‐Spratt, Kay E. Gurley, et al.. (2011). Tumor Microenvironment–Derived Proteins Dominate the Plasma Proteome Response during Breast Cancer Induction and Progression. Cancer Research. 71(15). 5090–5100. 69 indexed citations

Kelly‐Spratt, Karen S., Sharon J. Pitteri, Kay E. Gurley, et al.. (2011). Plasma Proteome Profiles Associated with Inflammation, Angiogenesis, and Cancer. PLoS ONE. 6(5). e19721–e19721. 35 indexed citations

Taguchi, Ayumu, Katerina Politi, Sharon J. Pitteri, et al.. (2011). Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models. Cancer Cell. 20(3). 289–299. 120 indexed citations

Tian, Yuan, Karen S. Kelly‐Spratt, Christopher J. Kemp, & Hui Zhang. (2010). Mapping Tissue-Specific Expression of Extracellular Proteins Using Systematic Glycoproteomic Analysis of Different Mouse Tissues. Journal of Proteome Research. 9(11). 5837–5847. 33 indexed citations

Kelly‐Spratt, Karen S., et al.. (2009). Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer. Oncogene. 28(41). 3652–3662. 37 indexed citations

10.

Letarte, Simon, David Campbell, James S. Eddes, et al.. (2008). Differential Plasma Glycoproteome of p19ARF Skin Cancer Mouse Model Using the Corra Label-Free LC-MS Proteomics Platform. Clinical Proteomics. 4(3-4). 105–116. 11 indexed citations

11.

Kelly‐Spratt, Karen S., et al.. (2008). A Mouse Model Repository for Cancer Biomarker Discovery. Journal of Proteome Research. 7(8). 3613–3618. 19 indexed citations

12.

Tian, Yuan, Karen S. Kelly‐Spratt, Christopher J. Kemp, & Hui Zhang. (2008). Identification of Glycoproteins from Mouse Skin Tumors and Plasma. Clinical Proteomics. 4(3-4). 117–136. 14 indexed citations

13.

Bailey, S. Lawrence, et al.. (2008). Tumor Suppression by p53 in the Absence of Atm. Molecular Cancer Research. 6(7). 1185–1192. 12 indexed citations

14.

Ruddell, Alanna, Karen S. Kelly‐Spratt, Momoko Furuya, Sean S Parghi, & Christopher J. Kemp. (2007). p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis. Oncogene. 27(22). 3145–3155. 41 indexed citations

15.

Besson, Arnaud, et al.. (2006). A pathway in quiescent cells that controls p27^Kip1 stability, subcellular localization, and tumor suppression. Genes & Development. 20(1). 47–64. 174 indexed citations

16.

Kelly‐Spratt, Karen S., Kay E. Gurley, Yutaka Yasui, & Christopher J. Kemp. (2004). p19 Arf Suppresses Growth, Progression, and Metastasis of Hras-Driven Carcinomas through p53-Dependent and -Independent Pathways. PLoS Biology. 2(8). e242–e242. 69 indexed citations

17.

Zhang, Hui, Eugene C. Yi, Xiaojun Li, et al.. (2004). High Throughput Quantitative Analysis of Serum Proteins Using Glycopeptide Capture and Liquid Chromatography Mass Spectrometry. Molecular & Cellular Proteomics. 4(2). 144–155. 175 indexed citations

18.

Kelly‐Spratt, Karen S., Laura J. Klesse, & Luis F. Parada. (2002). BDNF activated TrkB/IRR receptor chimera promotes survival of sympathetic neurons through Ras and PI‐3 kinase signaling. Journal of Neuroscience Research. 69(2). 151–159. 18 indexed citations

19.

Kelly‐Spratt, Karen S., Laura J. Klesse, Jussi Merenmies, & Luis F. Parada. (1999). A TrkB/insulin receptor-related receptor chimeric receptor induces PC12 cell differentiation and exhibits prolonged activation of mitogen-activated protein kinase.. PubMed. 10(12). 805–12. 20 indexed citations

20.

Bates, Carlton M., Jussi Merenmies, Karen S. Kelly‐Spratt, & Luis F. Parada. (1997). Insulin receptor-related receptor expression in non-A intercalated cells in the kidney. Kidney International. 52(3). 674–681. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact